Tranexamic Acid vs Vitamin C
Which is right for your skin?
Tranexamic acid targets melasma and hormonal discoloration at the source; vitamin C brightens and protects against daily sun damage. Melasma → tranexamic acid; overall radiance → vitamin C.
Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.
Brightens dull skin and helps fade dark spots. Also defends against everyday UV and pollution damage when worn under sunscreen.
Can you use Tranexamic Acid and Vitamin C together?
Yes — Tranexamic Acid and Vitamin C are documented to pair well together.
You want brightening. Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.
You want brightening, antioxidant. Brightens dull skin and helps fade dark spots. Also defends against everyday UV and pollution damage when worn under sunscreen.
Cited research
Liang Y et al., Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis, Journal of Cosmetic Dermatology 2024 — oral TXA + topical agents most effective delivery route
Tranexamic Acid Ameliorates Skin Hyperpigmentation by Downregulating Endothelin-1 Expression in Dermal Microvascular Endothelial Cells, Annals of Dermatology 2024;36(3):151-162 — mechanism study showing oral TXA suppresses endothelin-1 in vascular endothelial cells
Feng X et al., Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials, Journal of Clinical Pharmacy and Therapeutics 2021 — oral TXA is effective and safe for melasma, especially as adjuvant
MFDS Notified Functional Cosmetic Active — Tranexamic Acid (whitening). Korean Ministry of Food and Drug Safety, Cosmetic Functional Active Ingredient List — notified whitening active under the Korean Functional Cosmetics Codex; plasmin-inhibitor mechanism interrupts UV-triggered melanogenesis
Tranexamic Acid Diminishes Laser-Induced Melanogenesis, Annals of Dermatology 2015;27(3):250-256 — TXA reduces melanin production and tyrosinase activity in melanocytes; candidate for post-inflammatory hyperpigmentation
Na JI et al., Effect of tranexamic acid on melasma: a clinical trial with histological evaluation, Journal of the European Academy of Dermatology and Venereology 2013 — topical TXA reduced melasma severity with corresponding histological pigment reduction
Maeda K, Naganuma M, Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation, Journal of Photochemistry and Photobiology B 1998;47(2-3):136-41
Pullar JM et al., The roles of vitamin C in skin health, Nutrients 2017;9(8):866 — concluded topical efficacy "poorly understood"; supports dietary vitamin C
MFDS Approved Functional Cosmetic Active — Ascorbic Acid and derivatives (whitening). Korean Ministry of Food and Drug Safety, Cosmetic Functional Active Ingredient List — L-ascorbic acid and stabilized derivatives (Magnesium Ascorbyl Phosphate, Ethyl Ascorbic Acid, Sodium Ascorbyl Phosphate) are approved whitening actives in the Korean Functional Cosmetics Codex; authorized concentrations documented in Jeon JS et al., International Journal of Cosmetic Science 2016;38(3):286-93 (PMID:26564311)
Lee WJ et al., Magnesium Ascorbyl Phosphate Regulates the Expression of Inflammatory Biomarkers in Cultured Sebocytes, Annals of Dermatology 2015;27(4):376-82 — stable vitamin C derivative MAP suppresses inflammatory biomarkers in sebocytes, supporting anti-acne use
Telang PS, Vitamin C in dermatology, Indian Dermatology Online Journal 2013;4(2):143-146 — comprehensive review of topical vitamin C in photoaging and hyperpigmentation; concludes delivery challenges remain key limitation
Haftek M et al., Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin, Experimental Dermatology 2008;17(11):946-52 — 6-month topical ascorbic acid + madecassoside produced measurable improvement in photoaged skin clinical and structural endpoints
CIR Safety Assessment of Ascorbic Acid and related ascorbates as Used in Cosmetics
Humbert PG et al., Topical ascorbic acid on photoaged skin: Clinical, topographical and ultrastructural evaluation, double-blind study vs. placebo, Experimental Dermatology 2003;12(3):237-44 — 5% vitamin C cream produced clinically significant improvement in sun-damaged skin with corroborating ultrastructural changes
Lin JY et al., UV photoprotection by combination topical antioxidants vitamin C and vitamin E, Journal of the American Academy of Dermatology 2003;48(6):866-74 — RCT in pig skin model demonstrating significant UV-erythema reduction from combined topical L-ascorbic acid + α-tocopherol
Boyce ST et al., Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes, Journal of Investigative Dermatology 2002;118(4):565-72 — vitamin C in culture media enhances keratinocyte viability, basement-membrane formation, and barrier strength
Haftek M, Creidi P, Richard A, Humbert P, Schmitt D, Rougier A, Topically applied ascorbic acid helps to restructure chronically photodamaged human skin, European Journal of Dermatology 2002;12(4):XXVII-XXIX — French team (INSERM U346/CNRS Lyon, Besancon): topical vitamin C produced ultrastructural restructuring of chronically photodamaged skin
Zahouani H, Rougier A, Creidi P, Richard A, Humbert P, Interest of a 5% vitamin C w/o emulsion in the treatment of skin aging: effects on skin relief, European Journal of Dermatology 2002;12(4):XXIII-XXVI — Ecole Centrale Lyon + Besancon group: 5% vitamin C cream improved skin relief in aging
Leveque N, Muret P, Mary S, Makki S, Kantelip JP, Rougier A, Humbert P, Decrease in skin ascorbic acid concentration with age, European Journal of Dermatology 2002;12(4):XXI-XXII — Besancon CHU pharmacology group quantified age-related decline in cutaneous ascorbate, providing rationale for topical supplementation
Nusgens BV et al. (Univ. Liège, Belgium / collab. with Humbert at Besançon), Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis, Journal of Investigative Dermatology 2001;116(6):853-9 — clinical trial demonstrating topical vitamin C significantly upregulates collagen I/III mRNA and TIMP-1 in postmenopausal-women dermis
Every entry points to a specific paper or regulatory document. See methodology for what each outcome label means.